Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2025-12-24 @ 1:32 PM
NCT ID:
NCT05084495
Eligibility Criteria:
Inclusion Criteria:
* All patients with written informed consent who are eligible for flecainide treatment for atrial fibrillation.
* The patients must be followed at the Skånes hospitals northwest and Skånes university hospitals.
* Age \>18 years
Exclusion Criteria:
* Flecainide treatment with other indication than atrial fibrillation (including atrial flutter).
* No secure date for treatment start.
* Age \<18 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05084495
Study Brief:
Protocol Section:
NCT05084495